Screener
ClearPoint Neuro CLPT Income Tax
Income Tax at other companies
Other financials
Where this comes from
Reported directly by ClearPoint Neuro in its filing.
Tagged under the XBRL concept us-gaap:IncomeTaxExpenseBenefit.
The source filing: ClearPoint Neuro’s 10-Q, filed May 13, 2026.
- Filed
- May 13, 2026, 5:00 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-221890
| Line item | For the Three Months Ended March 31, 2026 | For the Three Months Ended March 31, 2025 |
|---|---|---|
| Interest income | 351 | 151 |
| Interest expense | (1,382) | — |
| Net loss before income taxes | (9,544) | (6,008) |
| Income tax expense | 8 | 18 |
| Net loss | $(9,552) | $(6,026) |
| Net loss per share attributable to common stockholders: | ||
| Basic and diluted | $(0.32) | $(0.22) |
| Weighted average shares outstanding: |
ITEM 1. FINANCIAL STATEMENTS
FAQ
- What is ClearPoint Neuro's income tax?
- ClearPoint Neuro (CLPT) reported income tax of $8K in Q1 2026.
- How has ClearPoint Neuro's income tax changed year-over-year?
- ClearPoint Neuro's income tax decreased by 55.6% year-over-year, from $18K to $8K.
- What does income tax mean?
- Total income tax expense (current + deferred) recognized in the income statement, representing the company's total tax obligation on pre-tax income.
Ask your AI about ClearPoint Neuro's income tax.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude